Literature DB >> 25218334

The influence of mtDNA deletion on lung cancer cells under the conditions of hypoxia and irradiation.

Cheng-Bo Han1, Li Sun, Jie-Tao Ma, Yao-Yong Li, Shu-Ling Zhang, Dong-Mei Bai, Yang Zhou, Le-Tian Huang.   

Abstract

PURPOSE: This study was to evaluate the influence of mtDNA deletion on the lung cancer cells under the conditions of hypoxia or irradiation.
METHOD: The treatment conditions of lung cancer cell lines with (A549) and without mtDNA (ρ0A549: obtained by inducing from A549) included 2 h of hypoxia and 4 Gy irradiation (group 1: without treatment; group 2: 2 h of hypoxia; group 3: 4 Gy irradiation; group 4: 2 h of hypoxia plus 4 Gy irradiation). The Human OneArray™ microarray was used to hybridize with the Cy5-labeled aRNA in microarray sample preparation. Differentially expressed genes (DEGs) between the lung cancer cells with and without mtDNA were identified using NOISeq package in R. Gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed using the online tool of DAVID. RESULT: In the KEGG pathway analysis of down-regulated DEGs, nineteen pathways were simultaneously enriched in the four groups, which were mainly metabolism- and biosynthesis-related pathways. Nine lung cancer-related pathways were enriched in group 4, and more cancer-associated DEGs, such as MYC, MAX, and E2F1 were found in group 4 than in the other groups.
CONCLUSION: The mtDNA deletion could inhibit the biosynthesis and metabolism of lung cancer cells and promote the effect of hypoxia and radiation on lung cancer cells. MYC might be the key gene of the cooperation of hypoxia and radiation and MYC, MAX, and E2F1 might play roles in hypoxia- and radiation-induced cell death in lung cancer cells without mtDNA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25218334     DOI: 10.1007/s00408-014-9639-9

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  44 in total

1.  Prognostic factors for survival in stage III non-small-cell lung cancer treated with definitive radiation therapy: impact of tumor volume.

Authors:  Kiyoshi Basaki; Yoshinao Abe; Masahiko Aoki; Hidehiro Kondo; Yoshiomi Hatayama; Shigeyuki Nakaji
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-13       Impact factor: 7.038

2.  Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study.

Authors:  Martijn A Spruit; Paul P Janssen; Sonja C P Willemsen; Monique M H Hochstenbag; Emiel F M Wouters
Journal:  Lung Cancer       Date:  2006-03-09       Impact factor: 5.705

3.  Mitochondrial DNA copy number and lung cancer risk in a prospective cohort study.

Authors:  H Dean Hosgood; Chin-San Liu; Nathaniel Rothman; Stephanie J Weinstein; Matthew R Bonner; Min Shen; Unhee Lim; Jarmo Virtamo; Wen-ling Cheng; Demetrius Albanes; Qing Lan
Journal:  Carcinogenesis       Date:  2010-02-22       Impact factor: 4.944

4.  BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore.

Authors:  C Vande Velde; J Cizeau; D Dubik; J Alimonti; T Brown; S Israels; R Hakem; A H Greenberg
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 5.  Radiation-induced cell death mechanisms.

Authors:  David Eriksson; Torgny Stigbrand
Journal:  Tumour Biol       Date:  2010-05-20

Review 6.  Radiation-induced apoptosis: relevance to radiotherapy.

Authors:  W C Dewey; C C Ling; R E Meyn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-11-01       Impact factor: 7.038

7.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

8.  Suppression of radiation-induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase.

Authors:  D K St Clair; X S Wan; T D Oberley; K E Muse; W H St Clair
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

9.  Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway.

Authors:  Nobuko Koshikawa; Jun-Ichi Hayashi; Akira Nakagawara; Keizo Takenaga
Journal:  J Biol Chem       Date:  2009-10-01       Impact factor: 5.157

10.  Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.

Authors:  Cecilia Garofalo; Mariantonietta Capristo; Maria Cristina Manara; Caterina Mancarella; Lorena Landuzzi; Antonino Belfiore; Pier-Luigi Lollini; Piero Picci; Katia Scotlandi
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.